R&D Tax Credit Report 2026: BSFZ figures and reform
The BSFZ has received 63,718 R&D projects from 26,042 companies since September 2020 (as of 30 June 2026). The 2026 reform raises the assessment basis (Bemessungsgrundlage) to EUR 12 million.
- 93 NOVARIS applications, all approved, 6 weeks to decision on average
- 63,718 R&D projects applied for at the BSFZ (as of 30 June 2026)
- 26,042 applicant companies since September 2020
- Assessment basis from 2026: EUR 12 million
Read the numbers in context
Figures and details
Source: BSFZ Current Figures (bescheinigung-forschungszulage.de)
Key facts in brief
Since launching in September 2020, 26,042 companies have filed 63,718 R&D projects with the BSFZ (as of 30 June 2026; by the end of 2025 it was 46,418 applications covering 56,761 projects). The three most common rejection reasons are an unclearly explained technical risk, a missing distinction from the state of the art, and projects that do not meet the R&D definition under § 2 FZulG. The 2026 reform raises the assessment basis to EUR 12 million; ZEW estimates the annual funding volume afterward at around EUR 4 billion. Our own analysis of 93 NOVARIS applications shows: all approved, 6 weeks to decision on average, queries on around 70 %, always on technical risk or novelty. All key figures are summarised on the Forschungszulage facts 2026 page.
What do 93 BSFZ applications from NOVARIS practice show?
Our own analysis of every certification application NOVARIS has handled, as of 10/2026. The BSFZ itself publishes neither an approval rate nor processing times per application.
| Metric | Value |
|---|---|
| BSFZ applications handled | 93¹, including 25 since NOVARIS Consulting GmbH was founded in 2026 |
| Companies supported | more than 50 |
| Approved (positive BSFZ certificate) | 93 of 93, i.e. 100 % |
| BSFZ processing time, submission to decision | 6 weeks on average |
| Applications with a BSFZ query | around 70 % |
| Subject of the queries | in every case technical risk or novelty compared with known solutions |
| Eligible costs per project | around EUR 1 million on average |
| Funded costs per client and year | around EUR 1.4 million on average |
| Financial years claimed retroactively | usually 4 |
| Tax office, application to payout | usually around 2 weeks, depending on the tax office |
Source: NOVARIS analysis, 93 applications, as of 10/2026
The key finding lies in the queries: the BSFZ asks follow-up questions on around 70 % of applications, and every one of those queries concerned the technical risk or the novelty compared with known solutions, that is, the criteria of § 2 FZulG. An application that clearly sets out how the project differs from the state of the art and why the outcome is uncertain answers the most frequent query in advance. How to respond to a query is covered on the page BSFZ rejection and objection.
The funded costs form the assessment basis; the research allowance amounts to 25 % of it, 35 % for SMEs (§ 4 (1) FZulG). The application to the tax office can only be filed after the end of the financial year, in practice together with the annual financial statements. Since four financial years are usually claimed retroactively, a review also pays off for projects completed long ago: claiming the research allowance retroactively.
How does the research allowance market look in 2026?
More funding volume meets a stricter BSFZ review.
| Metric | Value | Source |
|---|---|---|
| Applicant companies since 09/2020 | 26,042 (as of 30 June 2026) | BSFZ |
| R&D projects applied for since 09/2020 | 63,718 (as of 30 June 2026) | BSFZ |
| BSFZ applications by the end of 2025 | 46,418 covering 56,761 projects | BSFZ |
| Estimated funding volume from 2026 | around EUR 4 billion a year | ZEW |
The cap on the assessment basis has risen from EUR 4 million in 2020 to EUR 12 million, while BSFZ applications grew from 46,418 by the end of 2025 to 63,718 projects applied for as of 30 June 2026. The BSFZ does not publish an approval rate broken down by year.
How has the research allowance developed since 2020?
63,718 projects from 26,042 companies in just under six years, with untapped potential: only around two thirds of R&D-active companies know the research allowance.
| Period | Applications | Projects |
|---|---|---|
| By the end of 2025 | 46,418 | 56,761 |
| As of 30 June 2026 | over 46,418 | 63,718 |
The BSFZ does not publish an approval rate broken down by year. Per the Stifterverband R&D survey, only around two thirds of R&D-active companies are even aware of the research allowance.
Sources: BSFZ Current Figures, Stifterverband R&D Survey 2024, ZEW Policy Brief 09/2025.
Why are BSFZ applications rejected?
The BSFZ does not publish a rejection rate; three reasons explain most of the rejections NOVARIS sees in its own mandates.
- Technical risk unclearly explained: the project describes a new development but does not convincingly explain why the outcome is open. The BSFZ requires a clear account of the open research questions.
- Missing distinction from the state of the art: the application does not show what goes beyond existing knowledge. Without that distinction, proof of novelty is missing.
- Non-eligible project: the project does not meet the R&D definition under § 2 FZulG, often in cases of pure software adaptation, quality assurance or market research.
All 93 BSFZ applications analysed were approved, including all 25 since NOVARIS Consulting GmbH was founded (as of 10/2026), see the analysis above. See Results for details.
How much research allowance do the 2026 rates actually produce?
Three model calculations under the current rates: 25% funding rate, 35% for SMEs, plus the 20% flat rate for new projects.
SME with a small R&D team
Five full-time developers on a new project starting in 2026.
Mid-size company with its own R&D department
A larger development department plus contract research with an EEA institute.
Large enterprise, multiple R&D projects
Over 250 employees, no SME bonus, several parallel projects.
For an individual calculation across several years, use the research allowance calculator.
What does the 2026 reform change about the research allowance?
The cap on the assessment basis rises for the third time since the FZulG began, and an overhead flat rate is added.
| Period | Assessment basis | Contract research | Overhead flat rate |
|---|---|---|---|
| From 1 July 2020 | EUR 4 million | 60% | none |
| From 28 March 2024 | EUR 10 million | 70% | none |
| From 1 January 2026 | EUR 12 million | 70% | 20% (only for projects started after 31 December 2025) |
ZEW estimates the annual funding volume from 2026 at around EUR 4 billion (ZEW Policy Brief 09/2025).
What companies should do now
- Apply retroactively. The fiscal years from 2022 are open while the four-year assessment period is running (§ 12 FZulG in conjunction with § 169 AO); for 2022 it ends on 31 December 2026.
- Introduce time tracking. Without project-based time records, own contributions and personnel costs cannot be proven.
- Check your SME status. 35% instead of 25% funding rate means 40% more allowance on the same assessment basis.
Which questions about the 2026 report come up most often?
What does this mean for your company?
Four conclusions from the report for your own application.
- The higher cap from 2026 makes it worth reviewing open tax years retroactively, not just the current project.
- As application volume grows, a clearly reasoned project description becomes more important.
- SME status pays off twice: a higher funding rate and a growing share of the rising funding volume.
- The three most common rejection reasons are avoidable: state the technical risk concretely, distinguish clearly from the state of the art, and check the scope of § 2 FZulG in advance.
Which industries use the research allowance?
Every industry is eligible; the BSFZ reviews the project, not the industry code.
The research allowance is open to every company liable to tax in Germany (§ 1 FZulG). What gets certified is a project that demonstrates novelty, technical risk and a systematic approach (§ 2 FZulG), whether it comes from a workshop, a laboratory or a software team. The distribution by industry is published by the BSFZ only as a chart (the ten most frequent sectors, updated quarterly).
| Industry | Typical R&D projects | Guide |
|---|---|---|
| Software & IT | Novel algorithms, architectures and data processing methods with an open technical outcome; routine programming and adapting known software are not R&D. | Research allowance Software & IT |
| Mechanical engineering | Novel kinematics, drive and control concepts, manufacturing processes, test carriers and prototypes. | Research allowance Mechanical engineering |
| Pharma & life sciences | Drug screening, formulation development, bioprocesses, analytical method development, clinical trials in Phase I to III. | Research allowance Pharma & life sciences |
| Automotive & mobility | Novel drivetrain, battery and control concepts, autonomous driving functions, lightweight structures, manufacturing processes. | Research allowance Automotive & mobility |
| Medical technology | Novel operating principles, control concepts, sensors, algorithms and manufacturing processes for medical devices. | Research allowance Medical technology |
| Energy & cleantech | Novel cell and stack concepts, storage chemistry, power electronics, grid control algorithms, pilot plants. | Research allowance Energy & cleantech |
| Aerospace | Novel propulsion, structural and avionics concepts, qualification trials, test articles. | Research allowance Aerospace |
| Agriculture & food tech | Novel processes, formulations, cultivation systems and testing methods. | Research allowance Agriculture & food tech |
| Construction | New construction methods, building materials, components and processes with an open technical question; structural design beyond established codes of practice. | Research allowance Construction |
Routine work is not eligible in any industry: adapting known solutions, building and operating to a fixed concept, market observation, training. The line is drawn by the project, not by the industry.
Clarify your own funding potential in a first consultation
We classify your R&D projects under § 2 FZulG. No result, no invoice.
Book a first consultationRead on
- Research allowance: the factsFunding rate, cap, deadlines and legal basis on one page
- Research allowance calculatorAssessment basis and allowance across several years.
- Research allowance amountFunding rate, assessment basis and maximum in detail.
- Research allowance consultingHow the collaboration with NOVARIS works.
- How to apply for the research allowanceBSFZ application and research allowance application (ELSTER) step by step.
- ResultsOur research allowance numbers, no invented names.
- Research Allowance GuideRequirements, process and 2026 updates at a glance.
Max Nodes
Founder and Managing Director of NOVARIS Consulting. Specialised in the German R&D tax credit (FZulG) since 2021; 25 of 25 accompanied BSFZ applications approved (as of 09/2026). Max Nodes